Literature DB >> 26017306

Cancer: Precise control of localized signals.

Vuk Stambolic1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26017306     DOI： 10.1038/nature14531

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  13 in total

1.  Novel mechanism of PTEN regulation by its phosphatidylinositol 4,5-bisphosphate binding motif is critical for chemotaxis.

Authors:  Miho Iijima; Yi Elaine Huang; Hongbo R Luo; Francisca Vazquez; Peter N Devreotes
Journal:  J Biol Chem       Date:  2004-02-05       Impact factor: 5.157

2.  Stabilization and productive positioning roles of the C2 domain of PTEN tumor suppressor.

Authors:  M M Georgescu; K H Kirsch; P Kaloudis; H Yang; N P Pavletich; H Hanafusa
Journal:  Cancer Res       Date:  2000-12-15       Impact factor: 12.701

3.  hVps34 is a nutrient-regulated lipid kinase required for activation of p70 S6 kinase.

Authors:  Maya P Byfield; James T Murray; Jonathan M Backer
Journal:  J Biol Chem       Date:  2005-07-27       Impact factor: 5.157

4.  Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association.

Authors:  J O Lee; H Yang; M M Georgescu; A Di Cristofano; T Maehama; Y Shi; J E Dixon; P Pandolfi; N P Pavletich
Journal:  Cell       Date:  1999-10-29       Impact factor: 41.582

5.  SUMO1 modification of PTEN regulates tumorigenesis by controlling its association with the plasma membrane.

Authors:  Jian Huang; Jie Yan; Jian Zhang; Shiguo Zhu; Yanli Wang; Ting Shi; Changhong Zhu; Cheng Chen; Xin Liu; Jinke Cheng; Tomas Mustelin; Gen-Sheng Feng; Guoqiang Chen; Jianxiu Yu
Journal:  Nat Commun       Date:  2012-06-19       Impact factor: 14.919

6.  INPP4B Is a PtdIns(3,4,5)P3 Phosphatase That Can Act as a Tumor Suppressor.

Authors:  Satoshi Kofuji; Hirotaka Kimura; Hiroki Nakanishi; Hiroshi Nanjo; Shunsuke Takasuga; Hui Liu; Satoshi Eguchi; Ryotaro Nakamura; Reietsu Itoh; Noriko Ueno; Ken Asanuma; Mingguo Huang; Atsushi Koizumi; Tomonori Habuchi; Masakazu Yamazaki; Akira Suzuki; Junko Sasaki; Takehiko Sasaki
Journal:  Cancer Discov       Date:  2015-04-16       Impact factor: 39.397

7.  In Vivo Role of INPP4B in Tumor and Metastasis Suppression through Regulation of PI3K-AKT Signaling at Endosomes.

Authors:  Chen Li Chew; Andrea Lunardi; Federico Gulluni; Daniel T Ruan; Ming Chen; Leonardo Salmena; Michiya Nishino; Antonella Papa; Christopher Ng; Jacqueline Fung; John G Clohessy; Junko Sasaki; Takehiko Sasaki; Roderick T Bronson; Emilio Hirsch; Pier Paolo Pandolfi
Journal:  Cancer Discov       Date:  2015-04-16       Impact factor: 39.397

Review 8.  PTEN loss in the continuum of common cancers, rare syndromes and mouse models.

Authors:  M Christine Hollander; Gideon M Blumenthal; Phillip A Dennis
Journal:  Nat Rev Cancer       Date:  2011-04       Impact factor: 60.716

Review 9.  The regulation and function of Class III PI3Ks: novel roles for Vps34.

Authors:  Jonathan M Backer
Journal:  Biochem J       Date:  2008-02-15       Impact factor: 3.857

10.  PTEN functions by recruitment to cytoplasmic vesicles.

Authors:  Adam Naguib; Gyula Bencze; Hyejin Cho; Wu Zheng; Ante Tocilj; Elad Elkayam; Christopher R Faehnle; Nadia Jaber; Christopher P Pratt; Muhan Chen; Wei-Xing Zong; Michael S Marks; Leemor Joshua-Tor; Darryl J Pappin; Lloyd C Trotman
Journal:  Mol Cell       Date:  2015-04-09       Impact factor: 17.970
View more
  2 in total

1.  Targeted Pten deletion plus p53-R270H mutation in mouse mammary epithelium induces aggressive claudin-low and basal-like breast cancer.

Authors:  Sharon Wang; Jeff C Liu; Danbi Kim; Alessandro Datti; Eldad Zacksenhaus
Journal:  Breast Cancer Res       Date:  2016-01-19       Impact factor: 6.466

2.  Common and distinct features of mammary tumors driven by Pten-deletion or activating Pik3ca mutation.

Authors:  Jeff C Liu; Dong-Yu Wang; Sean E Egan; Eldad Zacksenhaus
Journal:  Oncotarget       Date:  2016-02-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.